SEC Filing Summary for Edward L. Murphy - Co-Diagnostics, Inc.

This filing details transactions by Edward L. Murphy, a director at Co-Diagnostics, Inc. On May 23, 2026, Mr. Murphy acquired 1,695 shares of Common Stock. Concurrently, he disposed of 1,695 Restricted Stock Units (RSUs). These RSUs are linked to the Common Stock, with 5,695 underlying shares. Following these transactions, Mr. Murphy holds 11,084 shares of Common Stock and 4,000 RSUs. The RSUs awarded on June 12, 2023, April 26, 2024, and August 13, 2025, vest in six installments every six months, commencing November 23, 2023, November 23, 2024, and November 23, 2025, respectively. All transactions were made under the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan.